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HELPING PUBLIC OFFICIALS USE RESEARCH 
EVALUATING HEALTHCARE 
 
Daniel M. Fox, Ph.D. & Lee Greenfield, B.S.* 
INTRODUCTION 
In the health sector, “evidence-based research” refers to the 
methods, findings and potential uses of research evaluating the 
effectiveness of healthcare interventions in populations. For almost 
two decades, the authors of this article have been introducing 
legislators and senior officials of the executive branches of state 
governments to this body of research. In November 2005, we 
joined colleagues from research organizations and state 
governments to introduce evidence-based healthcare research to 35 
federal and 37 state court judges at the sixth session of Science for 
Judges, a program of the Center for Health, Science and Public 
Policy at Brooklyn Law School. To our knowledge, the workshops 
we describe here were the first sustained effort to communicate to 
public officials the basic concepts of state-of-the-art research 
evaluating health services. This article summarizes the history and 
significance of evidence-based healthcare research, and then 
describes and evaluates our experience of communicating basic 
knowledge about its scope and methods to public officials. 
                                                          
 * Daniel M. Fox, Ph.D. is President of the Milbank Memorial Fund. Lee 
Greenfield is the Senior Policy Adviser of the Hennepin County Department of 
Health Services and Public Health. This article is based on the authors’ personal 
experience of policymaking and of communicating research findings to officials 
of the three branches of government as well as on pertinent literature. One or 
both of the authors participated in the creation of any evidence presented in the 
article that is not accompanied by a citation. Copyright 2006, Daniel M. Fox & 
Lee Greenfield. 
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I. THE DEMAND FOR CREDIBLE RESEARCH EVALUATING HEALTH 
SERVICES 
Research findings about the effectiveness and quality of health 
services have had a growing influence on policy for financing and 
regulating health care for two decades.1 These findings derive from 
rigorous, quantitative analysis of events in populations. Previously, 
population-based research—with the significant exception of 
clinical trials of new drugs—had much less significance for 
policymakers than research conducted by health scientists in 
laboratories which clinical scientists then applied to small numbers 
of patients in the hospitals and clinics of academic health centers. 
The rising cost of healthcare led decision makers in 
government and private organizations that insure and provide care, 
such as HMOs, to demand reliable information about the quality 
and effectiveness of the services used by large groups of patients. 
The cost of care has been a growing burden on purchasers, payers, 
providers, and consumers since the 1960s. Although some of the 
cost increase resulted from advances in science and technology, 
expanded health coverage by the public and private sectors caused 
much of it. Expanded coverage raised costs in part because more 
people now had access to a greater variety of services. However, 
the primary reason that expanded coverage inflated costs was 
because public and private payers reimbursed hospitals and 
physicians generously while rarely, until the past decade, holding 
them accountable for the quality and effectiveness of care.2 
Since the 1960s, however, improvements in research methods, 
coupled with increased funding, have made researchers better 
                                                          
1 RAY MOYNIHAN, EVALUATING HEALTH SERVICES: A REPORTER COVERS 
THE SCIENCE OF RESEARCH SYNTHESIS (2004), available at 
http://www.milbank.org/reports/2004Moynihan/040330Moynihan.html; Iain 
Chalmers, Trying To Do More Good than Harm in Policy and Practice: The 
Role of Rigorous, Transparent and Up-to-Date Evaluations, 589 ANNALS OF 
THE AM. ACAD. OF POL. & SOC. SCI. 22, 22-40 (2003). 
2 See generally DANIEL M. FOX, POWER AND ILLNESS: THE FAILURE AND 
FUTURE OF AMERICAN HEALTH POLICY (1995). See also RICK MAYES, 
UNIVERSAL COVERAGE: THE ELUSIVE QUEST FOR NATIONAL HEALTH 
INSURANCE 81 (2004). 
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equipped to meet the rising demand from decision makers for 
rigorous evaluation of health services. The quantity and quality of 
research on populations that had the potential to inform policy 
actually began growing in the 1940s. By the late 1960s, the federal 
government had begun to finance the new field of health services 
research. This field is comprised of persons trained in 
epidemiology, biostatistics, economics, sociology, psychology and 
related disciplines of the social and management sciences. Before 
the 1960s, most researchers in these disciplines who studied health 
services had been advocates: some for universal coverage, and 
others for the policy preferences of the hospitals, medical 
associations, or public agencies that employed them. By the 1970s, 
as a result of federal funding and growing demand for faculty in 
the disciplines of health services research to carry out the missions 
of new and reorganized academic health centers, most researchers 
in the field exchanged advocacy for objectivity.3 
In the 1980s and early 1990s, advances in the methodology for 
research on the effects of health services on populations made it 
possible to evaluate with growing rigor the quality of care.4 Prior 
to these advances, evaluation of healthcare effectiveness was 
limited to the opinions of physicians about their peers. These 
opinions were almost always grounded in personal experience of 
practice and in extrapolation from observational research on small 
cohorts of patients. 
The new, population-based research on the effectiveness of 
health services was instantly controversial. For example, an early 
use of population-based analysis of medical records was to 
compare mortality rates for particular surgical procedures among 
hospitals. In the late 1980s, the New York State Department of 
Health began to conduct and publish an annual study of hospital 
mortality rates for heart bypass surgery. State officials explained 
                                                          
3 Daniel M. Fox, From Reform to Relativism: A History of Economists and 
Health Care, in 79 MILBANK MEMORIAL FUND Q: HEALTH & SOC’Y 297, 297-
336 (1979); Daniel M. Fox, Health Policy and the Politics of Research in the 
United States, 15 J. HEALTH POL. POL’Y & L. 481, 481-99 (1990). 
4 MAYES, supra note 2, at 109.  See generally ANDREW STEVENS ET AL., 
THE ADVANCED HANDBOOK OF METHODS IN EVIDENCE-BASED HEALTH CARE 
(2001). 
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the methodology for taking account of variation in severity and 
case mix among hospitals; the media reported on these 
adjustments. Nevertheless, many hospital executives and surgeons 
claimed that the adjusted mortality rates did not take full account 
of the complexity of their cases, and cited the study as an intrusive 
and arbitrary interference by state government.5 
The New York State research and its publication was, however, 
a success. Hospitals with the worst adjusted mortality rates 
recruited more skillful surgeons and improved the efficiency of 
their operating room teams. Those with the lowest mortality rates 
accepted with due modesty evidence that their rank improved their 
revenue. While some surgeons alleged that hospitals rejected 
complicated cases in order to improve their rates, evidence of such 
gaming was scarce.6 
More precise measures of the effectiveness of health services 
became available in the late 1980s and early 1990s. The 
availability of these measures was the basis of what researchers 
and policymakers called the “outcomes movement.” Some of these 
measures relied, like the New York State bypass surgery study, on 
the retrospective study of administrative data. Other measures were 
based on data for populations that researchers acquired 
prospectively in randomized controlled clinical trials and then 
synthesized using the methodology of “systematic reviewing” 
which had been introduced to health services research in the late 
1980s.  Systematic reviews were more compelling than previous 
methods of summarizing research for two reasons.  First, the 
reviewers reduced bias by subjecting studies of primary data to 
rigorous criteria for inclusion. Second, they compiled the results of 
the trials that met these criteria using a statistical procedure called 
meta-analysis. By the mid-1990s many people used the phrase 
“evidence-based medical (or healthcare) research” to describe both 
prospective and retrospective studies; others limited the phrase 
“evidence-based” to prospective studies and systematic reviews of 
                                                          
5 Edward L. Hannan et al., Improving the Outcomes of Coronary Artery 
Bypass Surgery in New York State, 271 JAMA 761, 761-66 (1994). 
6 Edward L. Hannan et al., The Decline in Coronary Artery Bypass Graft 
Surgery Mortality in New York State. The Role of Surgeon Volume, 273 JAMA 
209, 209-13 (1995). 
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them.7 
In particular, two aspects of this research had increasing 
relevance for policy makers. The first was mounting evidence that 
processes of care were often flawed, especially for patients with 
chronic disease; the second was the importance of patients’ 
opinions in conducting research on healthcare systems. Regarding 
flaws in medical care, research revealed that many patients 
suffered unnecessary pain or required hospitalization for acute 
manifestations of their diseases because physicians failed to order 
routine tests or to prescribe drugs that were the standard of care. 
Many more patients than had been expected died as a result of 
inappropriate care and medical errors. By the end of the 1990s, 
concern about this evidence stimulated reports, notably by the 
Institute of Medicine of the National Academies of Science, and 
activities that came to be called the “quality movement.”8 
The quality movement, using evidence from the overlapping 
methods of outcome and evidence-based research, challenged a 
century of conventional wisdom about the causes of progress in 
healthcare. Since the late nineteenth century, most decision makers 
in government, business, hospitals, and clinics had assumed that 
the findings of research in the basic biomedical sciences benefited 
patients by flowing down a hierarchy of organizations: from 
research laboratories to teaching hospitals to community hospitals 
and to ambulatory care. Physicians acquired new knowledge as 
medical students and house staff, through their required 
participation in programs of continuing medical education, and, 
perhaps most importantly, in conversations with colleagues. 
Physicians assured quality—that is, they policed the healthcare 
system—by reviewing the work of their peers as members of 
medical licensing boards (which certified specialists to practice) 
and hospital review committees. Physicians also had the power to 
police informally by choosing the specialists to whom they 
                                                          
7 See supra notes 1, 2, 4 and accompanying text. 
8 INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES OF SCIENCE, 
CROSSING THE QUALITY CHASM: A NEW HEALTH SYSTEM FOR THE TWENTY-
FIRST CENTURY (2001) (Executive Summary), available at 
http://www.astro.org/pdf/GR/IOM_Quality.pdf. 
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referred patients.9 
Evidence has mounted since the 1980s to contradict this 
conventional wisdom about medical progress. As a result, quality 
ceased to be a set of standards based on the opinions of leading 
physicians and assured by peer review. The impetus for the quality 
movement has been unassailable evidence that many physicians do 
not meet the standards of quality derived from research on 
interventions in populations. Many decision makers in the public 
and private sectors began to suspect that medical education, peer 
review, and prudent referrals may be less effective methods of 
improving the quality and safety of practice than incentives and 
disincentives that were communicated through reimbursement and 
regulatory policy. Economists, encouraged by decision makers, 
began to propose incentives and disincentives that could be 
adopted by purchasers in the public and private sectors as well as 
by groups of physicians, professional associations, hospitals, health 
plans, and regulatory agencies. 
The second significant result of evidence-based research in the 
policy arena was that it demonstrated the value of patients’ 
opinions about their care. Physicians had traditionally rejected or 
discounted patients’ opinions as, in a phrase many of them used, 
“merely subjective” in contrast to their supposed objectivity, based 
on knowledge of the basic and clinical sciences and experience in 
practice. But researchers concerned about outcomes found that 
patients’ evaluation of their care offered evidence about its 
quality.10 As a result, elected officials and corporate executives no 
longer had to be ambivalent or apologetic about heeding the 
opinions of their constituents or employees about their care. The 
first published “report cards” on health plans, in the early 1990s, 
summarized data about patients’ satisfaction with their care as well 
as objective measures such as the appropriate use of retinal 
screening for persons with diabetes. 
The backlash against managed care in the tight labor market of 
the late 1990s made it difficult for public and private purchasers of 
                                                          
9 See generally DANIEL M. FOX, HEALTH POLICIES, HEALTH POLITICS: THE 
BRITISH AND AMERICAN EXPERIENCE, 1911-65 (1986). 
10 Paul D. Cleary & Barbara J. McNeil, Patient Satisfaction as an Indicator 
of Quality, 25 INQUIRY 25, 25-36 (1988). 
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care to use information about outcomes to improve the quality of 
care. Large public and private sector purchasers had encouraged or 
required beneficiaries to enroll in health maintenance organizations 
mainly to contain costs, but also because these organizations could 
monitor what physicians did and the physicians’ results. They 
encouraged managed care organizations to use this evidence to 
improve the quality of care, mainly by restricting access to 
inappropriate treatment and emphasizing preventive services. 
Unfortunately, many Americans, firm believers in the conventional 
wisdom about the progress of medical science, complained when 
managed care organizations restricted their choice among 
physicians and denied coverage for care their physicians 
recommended. Many believed that managed care organizations 
often denied coverage for expensive services in order to increase 
their earnings. 
The backlash against managed care interrupted, but did not 
reverse, the commitment of purchasers in the public and private 
sectors to contain cost and improve quality. Healthcare cost 
inflation, which had slowed as a result of managed care, has again 
exceeded the national rate of inflation in recent years. 
Nevertheless, the quality movement has grown. One indicator of 
that growth is the media coverage of medical errors and other 
lapses in patient safety. In addition, fraud and abuse among 
providers has attracted growing attention from the public and, as a 
result, from leaders of the medical profession and hospitals. 
The supply of persuasive, strong findings from population-
based research on the effectiveness of health services is also 
growing. There continues to be an increase of “evidence-based 
research” studies being published in major academic journals, 
notwithstanding legitimate complaints that researchers are under-
funded, especially by the National Institutes of Health. Currently, 
more than 2,000 systematic reviews of healthcare interventions 
that meet international methodological standards are available; 
approximately 500 new or updated reviews are published each 
year.11 
                                                          
11 Daniel M. Fox, Evidence of Evidence-Based Policy: The Politics of 
Systematic Reviews in Coverage Decisions, 24 HEALTH AFF. 114, 115, 121 
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Most importantly, there is growing evidence that evidence-
based research is informing decisions by policymakers in many 
countries, including the United States. Systematic reviews are the 
most influential products of this research because of their high 
credibility, as described above.12 
II. INTRODUCING PUBLIC OFFICIALS TO EFFECTIVENESS RESEARCH 
For two decades, the authors of this article have helped to 
introduce policymakers to the methods and uses of research on the 
effectiveness of health services. Most of our efforts involved 
policymakers in state government. Each of us has considerable 
experience in state government. Greenfield was a legislative leader 
in Minnesota; Fox served in the executive branches in 
Massachusetts and New York. 
Moreover, each of us has firsthand knowledge of the 
communication problem between policymakers and researchers. 
These problems caused many on each side to be dismissive of 
those on the other. Some researchers did not describe their 
evidence and conclusions in language that was accessible to lay 
audiences. Others wanted policymakers to accept their authority as 
learned experts without much explanation of the basis of their 
knowledge. Many researchers believed that, absent experience, 
policymakers would be unable to appreciate or even understand 
their explanations. Worse still, other researchers found it easier to 
answer questions from policymakers that went beyond their 
knowledge by volunteering answers to questions that had not been 
asked. Moreover, researchers often recommended new policy with 
considerable conviction but then reminded policymakers that 
science is uncertain and probabilistic; that is, they became 
advocates who were willing to transfer the risk of error to public 
officials. 
Because of our interest in using the best available evidence to 
inform state policy, the authors welcomed invitations in the mid-
1980s to plan workshops in which state officials would learn about 
                                                          
(2005) [hereinafter Fox, Politics of Systematic Reviews in Coverage Decisions]. 
12 See MOYNIHAN, supra note 1; Chalmers, supra note 1. 
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the methods, uses, and results of the latest research on health 
services. These invitations came from Robert A. Fordham, 
Director of the User Liaison Program (ULP) of what was then the 
National Center for Health Services Research (NCHSR) in the 
Department of Health and Human Services. Fox had helped 
Fordham to plan and initiate the ULP when he was Associate 
Director of NCHSR for Academic and Inter-Governmental Affairs 
in the mid-1970s. In the early 1980s, after Greenfield began to 
attend ULP workshops, Fordham asked him to join the informal 
group of state officials who advised on the content and conduct of 
the workshops. 
The NCHSR was the principal source of federal support for 
research on the organization, delivery, and financing of health 
services. NCHSR was established in the late 1960s, in response to 
the increasing responsibilities of government at all levels for health 
planning, regulation, and direct services, to combat the rising costs 
of health care to government and private sector employers. The 
establishment of NCHSR was the first recognition by the federal 
government of the multi-disciplinary (and sometimes inter-
disciplinary) field of health services research. 
In the late 1970s, when Fordham initiated the ULP in his 
capacity as Associate Deputy Director of NCHSR, Congress had 
recently stripped NCHSR of much of its funding. At the time, 
members and staff of the House and Senate committees and sub-
committees responsible for financing healthcare regarded research 
sponsored by NCHSR or conducted by its staff as generally 
irrelevant to policy. Moreover, NCHSR had accorded priority in 
research to access rather than to cost containment since its 
inception through 1974, when economist Gerald Rosenthal was 
appointed Director of NCHSR. Rosenthal endorsed Fordham’s 
proposal to create ULP as one of a variety of projects to improve 
the reputation of NCHSR in Congress and in the health sector 
more generally.13 
Fordham relied almost entirely on state policymakers for 
                                                          
13 Daniel M. Fox, The Development of Priorities for Health Services 
Research: The National Center, 1974-76, 54 MILBANK MEMORIAL FUND Q: 
HEALTH & SOC’Y  237, 237-48 (1976). 
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advice on topics and methods to be dealt with by ULP workshops. 
Many of his senior colleagues in the NCHSR staff and many 
academics who did research on health services opposed ULP. They 
feared it would divert resources from investigator-initiated 
research in order to address the more pedestrian concerns of the 
public officials who were the “users” in ULP’s name. Moreover, 
when they failed to prevent the establishment of ULP, NCHSR 
colleagues and researchers advised Fordham to invite policy 
makers to attend lectures by academics instead of, as Fordham 
insisted, to participate in interactive discussions with them in 
groups limited to thirty people. This advice contradicted his 
experience with decision makers. During earlier service in other 
federal agencies, Fordham had earned a formidable reputation as 
an organizer of interactive workshops and he was adept at 
capturing the attention of policymakers. For example, in order to 
keep them focused on the material presented and prevent 
distractions from either business or pleasure, Fordham convened 
workshops at isolated sites, often with limited telephone lines. His 
favorite conference sites were the Rensselaerville Conference 
Center (forty-five miles from Albany, New York, over mountain 
roads) and Timberline Lodge, on Mt. Hood in Oregon. The postal 
address for Timberline, “Government Camp,” reassured public 
officials that they would not be accused of being on a junket when 
attending a ULP workshop. 
Fordham was also adept at holding policymakers’ attention in 
large part because of his meticulous planning for the ULP 
workshops. For example, he relied on the policymakers who 
advised ULP to help him set priorities for workshops and to review 
the content of each session of each workshop, often in several 
drafts, as well as each presenter’s performance at a rehearsal. 
Fordham and his advisers insisted that each speaker be 
knowledgeable about his or her subject and also be a skilled 
presenter. They believed that once a presenter lost a participant, 
that participant was usually lost for the rest of the workshop. The 
rehearsals minimized the loss of participants’ attention. Fordham 
required presenters at each new workshop and new presenters at 
repeated workshops to perform for a group of his advisers from 
state government. On their advice, he replaced the occasional weak 
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presenter. The advisers made suggestions about improving most 
presentations. As a result of this careful planning, officials who 
participated in ULP programs and evaluated various aspects of the 
workshops often described the quality of the presentations as the 
most significant characteristic of the ULP workshops. 
For example, ULP convened a workshop in the fall of 1990 to 
describe the latest findings from research on the effectiveness of 
health services, typically referred to at the time as “outcomes 
research,” and to discuss the relevance of these findings for state 
policy. Three distinguished researchers, all physicians, reluctantly 
and without doing much preparation appeared for a rehearsal about 
a month before the workshop: Elliott Fisher of Dartmouth College, 
Sheldon Greenfield,14 then of Tufts University (now University of 
California, Irvine), and J. Sanford Schwartz of the University of 
Pennsylvania. Participants found their presentations to be superb, 
most of all because of their active participation in group 
discussions, which followed another of Fordham’s rules that 
presenters should participate throughout a workshop. Afterwards, 
each of these researchers told Fordham’s advisers that their advice 
had improved their performance. All three subsequently 
participated in many ULP related activities. 
This workshop contributed another lesson about how to 
communicate the methods and results of research to policymakers 
since it provided the first opportunity to present the results of 
systemic reviews to health policymakers in the United States. 
During a visit to the United Kingdom several months earlier, one 
of us (Fox) met Iain Chalmers, who led an international group of 
researchers that had refined the methodology of research synthesis 
and applied it to perinatal care, in the first systematic reviews of an 
entire area of health services. A two-volume treatise based on this 
work was published in 1989 and was attracting considerable 
attention in Western Europe, Australia and Canada, but hardly any 
in the United States. In the final session of the ULP workshop, Fox 
presented slides of the first page of each of the appendices to 
Effective Care in Pregnancy and Childbirth.15 He asked the 
                                                          
14 No relation to the co-author of this paper. 
15 See generally IAIN CHALMERS ET AL., EFFECTIVE CARE IN PREGNANCY 
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participants to assume, for a moment, that the findings reported on 
the slides were based on the most sophisticated methodology for 
assessing the effectiveness of health services. Then he asked them 
to comment on the significance of the findings for policy. 
The slides arrayed interventions in perinatal care according to 
whether they were 1) effective, 2) ineffective, or 3) required 
additional research with primary data. Lee Greenfield was the first 
policymaker to speak. “These findings,” he said, “if they hold up, 
are an answer to a policymaker’s prayer.” After Fox outlined the 
methodology of systematic reviews, other participants concurred. 
As a result of the encouraging response at this workshop, the 
Milbank Memorial Fund (the Fund), which Fox had joined as 
President earlier that year, organized presentations about the 
methodology and findings of systematic reviews for other 
policymakers and for journalists.16 
Another result of this workshop was that two years (and many 
ULP presentations) later, Sheldon Greenfield volunteered to help 
the Fund assist decision makers to understand and use the new 
tools for evaluating the appropriateness and quality of health 
services. Fox convened Sheldon Greenfield, Lee Greenfield, who 
was then chair of the Health and Human Services Finance Division 
of the Minnesota House of Representatives, and Paul Cleary, an 
outcomes researcher then at the Harvard Medical School who was 
also the Editor of the Milbank Quarterly. They asked policymakers 
whether a report describing the methods and uses of outcomes 
research would be useful in their work and, if it would, what issues 
the report should address. Lee Greenfield moderated meetings of 
policymakers in both the legislative and executive branches of a 
representative group of states to discuss the feasibility and contents 
of such a report. Then he coordinated reviews of several drafts of 
the report by policymakers as well as researchers, and wrote its 
introduction. The Fund commissioned B.D. Colen, a Newsday 
columnist who had also reported on health policy for the 
Washington Post, to write the section of the report describing the 
                                                          
AND CHILDBIRTH (1989). 
16 See Earl Ubell, Are Births as Safe as They Could Be?, PARADE 
MAGAZINE, Feb. 7, 1993, at 9. 
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methods and uses of outcomes research. Cleary and Sheldon 
Greenfield wrote the concluding section, “Judging Quality 
Measures,” in response to requests from policymakers for a guide 
to assessing measures of quality presented to them by experts.17 
The Fund sent the completed report, Evaluating the Quality of 
Health Care: What Research Offers Decision Makers, to 
policymakers across the country. Their response to it was 
encouraging and several years later the Fund used a similar process 
to commission, review and publish Evaluating Health Services: A 
Reporter Covers the Science of Research Synthesis, by Ray 
Moynihan, an Australian journalist who had been covering 
evidence-based research for more than a decade.18 
By 1999, so many physicians were interested in the methods 
and uses of evidence-based healthcare research that the School of 
Medicine of the University of Colorado began to offer what 
became an annual five-day intensive workshop on the subject. 
Andy Oxman led the project, titled the Rocky Mountain Workshop 
on How to Practice Evidence-Based Health Care. It was supported 
by participants’ fees and the Agency for Healthcare Research and 
Quality in the federal Department of Health and Human Services. 
Oxman is an American physician who, in mid-career, entered 
government service in Norway to lead health services research. 
Before going to Norway, he was a faculty member in the 
Department of Clinical Epidemiology and Biostatistics at 
McMaster University in Ontario for 18 years. That department, 
chaired by David Sackett and then by Peter Tugwell, was the 
leading research group in North America in developing and 
applying the methodology of evidence-based research. Indeed, 
Oxman says that a McMaster colleague, Gordon Guyatt, invented 
the phrase “evidence-based medicine” one morning while the two 
of them were running. 
At the time of the inaugural Rocky Mountain Workshop, 
Oxman was also halfway through his term as Chair of the Steering 
Group of the Cochrane Collaboration, founded in Oxford, England 
                                                          
17 See generally LEE GREENFIELD ET AL., EVALUATING THE QUALITY OF 
HEALTH CARE: WHAT RESEARCH OFFERS DECISION MAKERS (1996). 
18 MOYNIHAN, supra note 1. 
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in 1992 by Iain Chalmers and colleagues from several countries. 
Members of the Collaboration conducted, coordinated, and 
published systematic reviews. By 2005, the Collaboration counted 
more than 12,000 members in more than 80 countries. The 
Cochrane Library, an electronic journal, was, and remains, the 
world’s largest source of systematic reviews.19 
Oxman and his colleagues brought to the Rocky Mountain 
Workshop the problem-based interactive pedagogy used with 
medical students and house staff at McMaster, and in training new 
systematic reviewers by the Cochrane Collaboration. The most 
important learning experiences during the workshop occurred in 
groups of eight persons, each led by the same two faculty members 
for the entire five days. Researchers on the faculty of the workshop 
presented the methodology of evidence-based health care to all the 
participants in plenary sessions. The groups applied the 
information presented at the plenaries, usually by analyzing a 
published article based on primary data or a systematic review. 
During the last seven years, the Rocky Mountain Workshop has 
helped to convert many physicians and policymakers into informed 
champions and users of evidence-based healthcare research. Since 
the early 1990s, moreover, the Milbank Memorial Fund had helped 
to disseminate information about the promise of systematic 
reviews to influence policy and practice in the United States. The 
Fund had also helped the founders of the Cochrane Collaboration 
make their case for funding to public agencies in the United 
Kingdom and the United States. Between 1994 and 1999, staff 
members of the Fund watched Cochrane develop, waiting to offer 
further assistance until the Collaboration was publishing a 
sufficient supply of new and updated systematic reviews to justify 
routine attention to its work by policy makers and members of 
their staff. By 1999, the collaboration was mature; the Cochrane 
Library had published 1,200 reviews, and researchers organized in 
fifty international groups were adding approximately 400 new 
reviews and updates each year. The Fund told Iain Chalmers, 
founder of the Collaboration, and Oxman, its chair, that it wanted 
to help broker systematic reviews to policy makers. As a result, in 
                                                          
19 See www.cochrane.org. 
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October 1999, Fox described reasons for miscommunication 
between policymakers and researchers at the opening plenary of 
the international Cochrane Colloquium in Rome, Italy. 
A few months after the international Colluquium, Oxman 
asked if the Fund could support the Rocky Mountain Workshop. 
Fox noted the similarity between the methods used at the workshop 
and those developed by the ULP and by the Fund on other projects. 
He suggested that Lee Greenfield become a faculty member for the 
workshop, and recommended that Greenfield and Oxman meet in 
Oslo to discuss a modified curriculum for policymakers. 
Greenfield and Oxman decided that policymakers attending the 
workshop would use the same basic text on methods and 
applications as the physician participants. This text had been 
written by faculty at McMaster for practitioners and teachers of 
evidence-based health care. But for policymakers’ work in their 
group, the two chose the scenarios, studies, and systematic reviews 
for group discussion on the basis of their experience of what they 
believed would interest policymakers. Greenfield then recruited 
eight policymakers for the workshop in August 2000. 
Since then, Greenfield has recruited six groups of policy 
makers to attend the Rocky Mountain Workshop. By 2005, 
eighteen legislators and twenty-two members of the executive 
branch from twenty-three States and one Canadian province had 
participated. These participants strongly approved of the 
workshop. A legislator told Greenfield, “I just can’t wait for 
someone to bring a phony study before my committee.” A 
participant from the executive branch reported that a colleague told 
him, “If I had known that the program was as good as it is, I would 
have read a lot more of the material in advance.” Another legislator 
asked to attend the workshop for a second time “because it has 
changed how I think about all policy, not just health policy.” 
The evaluation forms submitted by the policymakers after each 
workshop tell a similar story. Participants have consistently rated 
both the plenary sessions, in which faculty presented advances in 
methodology or new approaches to communicating research 
findings to various audiences, and the group sessions highly, often 
emphasizing that they learned a great deal in a very short amount 
of time. Many said that the groups and the computer labs were the 
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high points of the workshop. The researcher faculty members 
assigned to the group by Oxman, who change each year, 
consistently received the highest possible ratings and positive 
comments. Participants also rated Greenfield highly as the other 
faculty member for the group and wrote that they appreciated his 
ability to use and relate his experience as a policymaker in state 
and county government. 
Most of the policymakers who participated were also members 
of the Reforming States Group (RSG), a voluntary bipartisan 
organization of senior members of the executive and legislative 
branches of government of the fifty states and several Canadian 
provinces. RSG members meet regularly to exchange recent 
experience in the politics of policymaking for health under a non-
attribution rule. They also conduct projects to discover the best 
available evidence bearing on particular policies for healthcare and 
population health. 
At the three regional meetings of the RSG in 2003, members 
who had attended the Rocky Mountain Workshop, and several 
researchers who had served as their faculty, compressed the 
material in its textbook and the group discussions into a four-hour 
meeting that was attended by fifty of their colleagues who had not 
yet participated in the full workshop. A researcher introduced the 
methods of evidence-based research. Then Greenfield described 
principles of statistics, guiding them through a one-page list of 
concepts in about twenty minutes. RSG members who had 
attended the Rocky Mountain Workshop led small groups to 
analyze an article and then a systematic review. 
The systematic review discussed in the groups had been 
produced by the Drug Effectiveness Review Project (DERP). This 
project is currently governed and financed by seventeen states, the 
Canadian Coordinating Office for Healthcare Technology 
Assessment, and the California Health Care Foundation. The 
DERP produces systematic reviews comparing the effectiveness, 
safety and effect on sub-populations of competing drugs, in the 
therapeutic classes, that are among the most widely prescribed for 
beneficiaries of publicly funded health programs in the states and 
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provinces.20 
The DERP, a program that now informs policy for prescription 
drug coverage for more than half the enrollees in Medicaid 
nationally, vividly illustrates the central points in this article 
because it is a result of the convergence of the events we have 
described and of the network of persons who participated in them. 
Its inspiration was the policy of reference drug pricing introduced 
by the provincial government in British Columbia in 1994. Fox 
and Oxman had commissioned a case study of this policy for a 
meeting of policymakers and researchers who discussed how 
evidence informs policy in six countries.21 This meeting occurred 
in conjunction with the Cochrane Colloquium in Cape Town, 
South Africa in 2000. Fox and Oxman insisted that a policymaker 
be a co-author of each case in order to emphasize the relevance of 
research for decisions about policy.  At an RSG meeting six weeks 
later in December 2000, an Oregon official asked if anyone knew 
about evidence-based pharmaceutical policy in British Columbia. 
Fox gave him a draft of the case study written for the meeting in 
Capetown which he was editing for publication. A month later, 
Mark Gibson, an Oregon policy maker, who had been an adviser to 
the ULP as well as a participant in the Rocky Mountain Workshop, 
invited the policymaker who was a co-author of the British 
Columbia case study to visit the Governor’s office in Salem, 
Oregon. By July 2001, the Oregon legislature had enacted 
legislation signed by the Governor, creating an evidence-based 
preferred drug list. Policymakers from the first two states to join 
Oregon in financing the DERP, Idaho and Washington, had also 
participated in the Rocky Mountain Workshop. Other participants 
subsequently encouraged their states to join the DERP.22 
                                                          
20 See, e.g., OREGON HEALTH AND SCIENCE UNIVERSITY HOME PAGE, 
www.ohsu.edu/drugeffectiveness (last visited Apr. 24, 2006). 
21 INFORMING JUDGMENT: CASE STUDIES OF HEALTH POLICY AND 
RESEARCH IN SIX COUNTRIES (Daniel M. Fox & Andrew D. Oxman, eds., 2001), 
available at http://www.milbank.org/2001cochrane/010903cochrane. html. 
22 Fox, Politics of Systematic Reviews in Coverage Decisions, supra note 
11, at 119. 
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III. EVIDENCE-BASED HEALTHCARE RESEARCH AND THE JUDICIARY 
These converging individuals and events began to include the 
judicial branch of government in the spring of 2004. Margaret 
Berger, Suzanne J. and Norman Miles Professor of Law at  
Brooklyn Law School and organizer of a series of workshops titled 
Science for Judges, described the difference between legal and 
medical definitions of evidence at a meeting of the Cochrane 
Collaboration. Mark Gibson, now the director of the DERP, and 
based at the Oregon Health and Science University, spoke on the 
same panel. 
Fox soon asked Berger for advice about introducing judges to 
the methods and uses of evidence-based healthcare research. 
Berger suggested that this research could be the subject of Science 
for Judges VI, in November 2005, and she introduced Fox to senior 
officials of the Federal Judicial Center (FJC). FJC sponsors 
Science for Judges with the National Center for State Courts and 
the Committee on Science, Technology and Law of the National 
Academies of Science, and with financial support from the 
Common Benefits Trust established in the Silicone Breast Implant 
Products Liability Litigation. 
Science for Judges VI used the methods developed by the ULP 
and then elaborated in the activities described in this article. Most 
of the faculty, both researchers and policymakers, had participated 
in the Rocky Mountain Workshop. Two were leaders of the 
Cochrane Collaboration. One of them, Peter Tugwell, had chaired 
the pioneering Department of Clinical Epidemiology at McMaster 
University. The other, Lisa Bero, is a leading methodologist. Two 
researchers, Jeffrey Lerner and Diane Robertson, are at ECRI, a 
non-profit research organization that assesses healthcare 
technology and is also one of thirteen Evidence-Based Practice 
Centers in North America designated by the federal Agency for 
Healthcare Research and Quality (successor to the previously 
mentioned Agency for Healthcare Research and Policy).  Mark 
Helfand, a researcher who leads the preparation of systematic 
reviews for DERP, joined Mark Gibson in presenting and leading 
groups. Groups were also lead by Fox and Richard Gottfried, a 
New York State Assembly Member and Health Chair. Greenfield 
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helped compile a briefing book based on materials used at the 
Rocky Mountain Workshop and, with Mark Gibson, prepared the 
leaders of the small groups. 
The federal and state judges who attended Science for Judges 
VI reported that they had enjoyed and learned from the experience. 
Berger wrote that the immediate “feedback had been terrific.” 
Analysis of the evaluation forms had not been completed at the 
time of this writing but anecdotal evidence is strongly positive. A 
Virginia judge wrote Berger that the workshop “has given me an 
entirely new way to think about and question counsel who appear 
before me concerning many complex legal and science matters.”23 
A federal judge from New York City, David G. Trager, told Fox 
that he was likely to make greater use of court-appointed experts as 
a result of the workshop. Several judges expressed interest in the 
commissioning of bench books to inform them and their colleagues 
about the methods and uses of evidence-based healthcare research. 
Science for Judges VI reinforced the central argument of this 
article, that a participant-centered approach to informing 
government officials of the value of evidence-based research can 
assist those individuals who make decisions relevant to healthcare 
policy or adjudication. The initial responses of Science for Judges 
VI suggest that members of the judiciary can acquire useful 
information by experiencing a participant-centered methodology 
that was developed to inform policymakers in the executive and 
legislative branches of government about the methods and uses of 
research on the effectiveness of health services. This methodology 
is effective mainly because it accords priority to explaining how 
the best available scientific findings can inform significant 
decisions by judges and policy makers. It is also effective because 
it makes transparent the assumptions and methods of the research 
that yields the best findings. 
Science for Judges VI may also offer evidence about improving 
the relationship between the professions of law and medicine. 
Physicians and lawyers frequently disagree with each other. Some 
authors have characterized the relationships between these 
                                                          
23 Letter from the Hon. John J. McGrath, Jr. to Margaret A. Berger (Nov. 9, 
2005) (on file with author). 
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professions as a “conflict of cultures” that is rooted in different 
assumptions about how knowledge is acquired, what evidence is, 
and how to evaluate it.24 As law professors Peter Jacobson and M. 
Gregg Bloche have recently argued, however, “viewing physicians 
and attorneys as adversaries risks overlooking their shared values 
as professionals.”25 Deeper understanding of the methods and uses 
of evidence-based healthcare research and demonstrations of the 
relevance of its findings for decisions in all three branches of 
government may enable members of the health and legal 
professions to reason together on behalf of the public interest. 
CONCLUSION 
In sum, a positive result of changes in the cost and organization 
of healthcare in the United States during the past generation has 
been growing interest by decision makers in all three branches of 
government in a new body of research. This research is the basis of 
enhanced accountability of health professionals and provider 
organizations for the quality of care. We began this article by 
describing the economic and political circumstances that 
stimulated demand for this research by decision makers. Then we 
described what the authors and their colleagues have done to 
increase the access of decision makers to this research by 
informing them about its methods and findings. We also briefly 
described the Drug Evaluation Review Project (DERP) because it 
exemplifies how the process of informing decision makers we have 
described is contributing significantly to both improving the 
quality of healthcare and containing its cost. 
 
                                                          
24 Daniel M. Fox, Physicians versus Lawyers: A Conflict of Cultures, in 
AIDS AND THE LAW 367-76 (Harlan Dalton et al. eds., 1987). 
25 Peter D. Jacobson & M. Gregg Bloche, Improving Relations Between 
Attorneys and Lawyers, 294 JAMA 2083, 2083-85 (2005). 
